Stocktoria
Coherus Oncology, Inc. CHRS
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2014-11-06
Coherus Oncology, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 11,752,500 | $20.3M |
| TWO SIGMA INVESTMENTS, LP | 2,302,001 | $3.9M |
| AQR CAPITAL MANAGEMENT LLC | 1,206,046 | $2.0M |
| CITADEL ADVISORS LLC | 393,046 | $664,248 |
| RENAISSANCE TECHNOLOGIES LLC | 331,700 | $560,573 |
| MILLENNIUM MANAGEMENT LLC | 311,986 | $527,256 |
Source: SEC EDGAR filings · CIK 0001512762 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.